Preparing for the Philippine Medical Oncology Board Examination
Focus your preparation on mastering the ESMO/ASCO Global Curriculum 2016 framework, which provides the internationally recognized backbone for medical oncology training and directly aligns with board examination content worldwide, including the Philippines. 1
Core Study Framework
Primary Resource: ESMO/ASCO Global Curriculum
- The Global Curriculum 2016 comprises 12 sections with 17 subsections, 44 chapters, and 35 subchapters covering all essential medical oncology domains 1
- Learning objectives are organized into three hierarchical categories: awareness, knowledge, and skills—structure your study to master each level progressively 1
- The curriculum specifically addresses stratified therapy, targeted therapies by tumor entity, molecular pathology, translational research, personalized medicine, imaging, RECIST criteria, rare cancers, immunotherapy, and management of comorbidities 1
- A complementary Log Book serves as an assessment tool to track your competency development across all curriculum domains 1
Essential Content Areas to Master
Molecular Pathology and Precision Oncology:
- Systematic testing for EGFR mutations (exon 19 deletion, exon 21 L858R), ALK rearrangements, ROS1 rearrangements, and BRAF V600 mutations in advanced NSCLC 1
- Understanding when FISH, IHC, RT-PCR, and multiplex platforms are appropriate for molecular testing 1
- PD-L1 IHC interpretation for immunotherapy selection across treatment lines 1
- Molecular tumor board (MTB) case selection criteria: complex genomic profiles, unexpected findings, resistance biomarkers, rare cancers, and cases requiring non-standard treatments 1
Staging and Risk Assessment:
- AJCC/UICC 8th edition staging system application across tumor types 1
- RECIST v1.1 criteria for response evaluation, with understanding of irRECIST, iRECIST, and imRECIST for immunotherapy assessment 1
- Appropriate timing of imaging studies (6-9 weeks after systemic therapy initiation) 1
- Distinguishing when comprehensive staging is needed (locally advanced disease, positive nodes) versus when it adds no value (early stage N0 disease) 1
Tumor-Specific Management:
- Breast cancer: ER, PgR, HER2 testing methodologies; sentinel node biopsy indications; neoadjuvant versus adjuvant approaches 1
- Lung cancer: histology-driven treatment selection; molecular testing algorithms; management of T790M-mutant resistance 1
- Treatment strategy integration of histology, molecular pathology, age, performance status, and comorbidities 1
Supportive Care and Survivorship:
- The curriculum emphasizes cultural differences in supportive care, palliative care, end-of-life care, and geriatric oncology—understand both Western and Asian perspectives 1
- Survivorship care planning and long-term toxicity management 1
Study Strategy
Structured Learning Approach
- Begin with awareness-level content (recognizing concepts), progress to knowledge-level (understanding mechanisms), then master skills-level (clinical application) 1
- Use the Log Book format to systematically document your competency in each curriculum area 1
- Prioritize recent guideline updates (2016 onwards) as these reflect current standard-of-care that will be tested 1
Assessment Preparation
- The ESMO certification and ASCO in-training examinations align with the Global Curriculum content—practice questions from these sources directly prepare you for board examinations 1
- Focus on web-based objective examinations testing medical knowledge, indications/contraindications, pharmacology, and clinical scenario applications 1
- Practice structured clinical examinations (OSCE format) where you rotate through stations demonstrating procedures, interpretation skills, and clinical reasoning 2
Philippine-Specific Considerations
- Familiarize yourself with Philippine clinical practice guidelines, particularly the 2021 Well Differentiated Thyroid Cancer guidelines developed by the Department of Health 3
- Understand resource-limited adaptations: when to use screening approaches versus definitive testing, cost-effectiveness considerations, and treatment availability in the local setting 3
- Review Pan-Asian adapted guidelines (CSCO-ESMO initiatives) which address regional resource constraints while maintaining evidence-based standards 1
Practical Preparation Tips
Multidisciplinary Integration
- Understand the role of molecular tumor boards: case submission criteria, required documentation (clinical data, pathology reports, NGS results), and how recommendations are formulated 1
- Know when to involve surgical oncology, radiation oncology, radiology, and pathology in treatment planning 1
- Master informed consent processes for genomic profiling and clinical trial enrollment 1
Common Examination Pitfalls to Avoid
- Don't memorize isolated facts—understand the rationale behind testing algorithms and treatment sequences 1
- Avoid recommending routine tests that lack evidence (e.g., serum tumor markers like CEA for routine monitoring, PET for follow-up) 1
- Don't confuse screening recommendations across different age groups and risk categories 1
- Recognize when molecular testing is NOT indicated (e.g., squamous cell lung cancer in heavy smokers) 1
Time Management
- Allocate study time proportionally to the 12 major curriculum sections 1
- Dedicate extra time to rapidly evolving areas: immunotherapy, molecular diagnostics, and precision oncology 1
- Review tumor-specific chapters systematically rather than jumping between topics 1
Supplementary Resources
- Access ESMO and ASCO educational materials, webinars, and online platforms that cover Global Curriculum content 1, 4
- Utilize web-based patient simulations for clinical scenario practice 1
- Join study groups or online forums with other medical oncology trainees to discuss complex cases 4
The Global Curriculum represents the international standard for medical oncology competency—mastering its content ensures you meet the knowledge requirements for board certification while providing optimal patient care. 1